I agree. The market seems to be tightening up. Now the monkey is off the back about the finance, can't imagine too much bad news to come. That is unless the quarterly is not a shocker. A little bit of good news could tip the balance.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%